Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery

Nanotechnology

Volumn 21, Issue 41, 2010, Pages

  Yu, Mi Kyung ^a   Park, Jinho ^a   Jeong, Yong Yeon ^b   Moon, Woo Kyung ^c   Jon, Sangyong ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b Chonnam National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER DRUG; ARGININE-GLYCINE-ASPARTIC ACIDS; CANCER CELLS; CANCER IMAGING; CANCER-TARGETING; COMBINED IMAGING; DOXORUBICIN; HYDRODYNAMIC SIZE; IC50 VALUE; INTEGRINS; IONIC INTERACTION; MULTI-FUNCTIONAL NANOPARTICLES; PEPTIDE LIGAND; POLYMERIC COATINGS; PREFERENTIAL BINDING; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; THERAPEUTIC AGENTS;

AMINO ACIDS; DRUG DELIVERY; MAGNETIC RESONANCE; MEDICAL IMAGING; NANOPARTICLES; ORGANIC ACIDS; SUPERPARAMAGNETISM;

IRON OXIDES;

ANTINEOPLASTIC AGENT; CROSS LINKING REAGENT; CYCLIC ARGININE GLYCINE ASPARTIC ACID PEPTIDE; CYCLIC ARGININE-GLYCINE-ASPARTIC ACID PEPTIDE; CYCLOPEPTIDE; DIAGNOSTIC AGENT; DOXORUBICIN; IMMOBILIZED PROTEIN; INTEGRIN; MAGNETITE NANOPARTICLE;

ARTICLE; CHEMISTRY; CONFOCAL MICROSCOPY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG SCREENING; HUMAN; HYDRODYNAMICS; IC 50; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; SYNTHESIS; TEMPERATURE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CROSS-LINKING REAGENTS; DIAGNOSTIC IMAGING; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDRODYNAMICS; IMMOBILIZED PROTEINS; INHIBITORY CONCENTRATION 50; INTEGRINS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICROSCOPY, CONFOCAL; PARTICLE SIZE; PEPTIDES, CYCLIC; TEMPERATURE;

EID: 77958524401     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/21/41/415102     Document Type: Article

References (44)

1. Torchilin V P 2006 Adv. Drug Deliv. Rev. 58 1532-55
2. Sajja H K, East M P, Mao H, Wang Y A, Nie S and Yang L 2009 Curr. Drug Discov. Technol. 6 43-51
3. Lee J H, Lee K, Moon S H, Lee Y, Park T G and Cheon J 2009 Angew. Chem. Int. Edn Engl. 48 4174-9
4. Liong M, Lu J, Kovochich M, Xia T, Ruehm S G, Nel A E, Tamanoi F and Zink J I 2008 ACS Nano 2 889-96
5. Sanvicens N and Marco M P 2008 Trends Biotechnol. 6 425-33
6. Rhyner M N, Smith A M, Gao X, Mao H, Yang L and Nie S 2006 Nanomedicine 1 209-17
7. Kim K et al 2010 J. Control. Release 146 219-27
8. Lee K, Lee H, Bae K H and Park T G 2010 Biomaterials 31 6530-6
9. Jain T K, Richey J, Strand M, Leslie-Pelecky D L, Flask C A and Labhasetwar V 2008 Biomaterials 29 4012-21
10. Gao J, Gu H and Xu B 2009 Acc. Chem. Res. 42 1097-107
11. McCarthy J R and Weissleder R 2008 Adv. Drug Deliv. Rev. 60 1241-51
12. Yang J, Lee C H, Ko H J, Suh J S, Yoon H G, Lee K, Huh Y M and Haam S 2007 Angew. Chem. Int. Edn Engl. 46 8836-9
13. Veiseh O et al 2005 Nano Lett. 5 1003-8
14. Hadjipanayis C G, Machaidze R, Kaluzova M, Wang L, Schuette A J, Chen H, Wu X and Mao H 2010 Cancer Res. 70 6303-12
15. John R, Rezaeipoor R, Adie S G, Chaney E J, Oldenburg A L, Marjanovic M, Haldar J P, Sutton B P and Boppart S A 2010 Proc. Natl Acad. Sci. 107 8085-90
16. Thomas C R et al 2010 J. Am. Chem. Soc. 132 10623-5
17. Lee H, Lee E, Kim D K, Jang N K, Jeong Y Y and Jon S 2006 J. Am. Chem. Soc. 128 7383-9
18. Lee H, Yu M K, Park S, Moon S, Min J J, Jeong Y Y, Kang H W and Jon S 2007 J. Am. Chem. Soc. 129 12739-45
19. Yu M K, Jeong Y Y, Park J, Park S, Kim J W, Min J J, Kim K and Jon S 2008 Angew. Chem. Int. Edn Engl. 47 5362-5
20. Yang L et al 2009 Clin. Cancer Res. 15 4722-32
21. Huh Y M et al 2005 J. Am. Chem. Soc. 127 12387-91
22. Moore A, Medarova Z, Potthast A and Dai G 2004 Cancer Res. 64 1821-7
23. Brooks P C, Montgomery A M, RosenfeldM, Reisfeld R A, Hu T, Klier G and Cheresh D A 1994 Cell 79 1157-64
24. Brooks P C, Strömblad S, Klemke R, Visscher D, Sarkar F H and Cheresh D A 1995 J. Clin. Invest. 96 1815-22
25. Brooks P C, Clark R A and Cheresh D A 1994 Science 264 569-71
26. McCormick B A and Zetter B R 1992 Pharmacol. Ther. 53 239-60
27. Varner J A and Cheresh D A 1996 Curr. Opin. Cell Biol. 8 724-30
28. Dechantsreiter M A, Planker E, Mathä B, Lohof E, Hölzemann G, Jonczyk A, Goodman S L and Kessler H 1999 J. Med. Chem. 42 3033-40
29. Xie J, Chen K, LeeH Y, Xu C, Hsu A R, Peng S, Chen Xand Sun S 2008 J. Am. Chem. Soc. 130 7542-3
30. Mulder W J, Koole R, Brandwijk R J, Storm G, Chin P T, Strijkers G J, de Mello Donegá C, Nicolay K and Griffioen A W 2006 Nano Lett. 6 1-6
31. Montet X, Montet-Abou K, Reynolds F, Weissleder R and Josephson L 2006 Neoplasia 8 214-22
32. Cai W, Chen K, Li Z B, Gambhir S S and Chen X 2007 J. Nucl. Med. 48 1862-70
33. Han H D et al 2010 Clin. Cancer Res. 16 3910-22
34. Murphy E A, Majeti B K, Barnes L A, Makale M, Weis S M, Lutu-Fuga K, Wrasidlo W and Cheresh D A 2008 Proc. Natl Acad. Sci. USA 105 9343-8
35. Nasongkla N et al 2006 Nano Lett. 6 2427-30
36. Cai W, Shin D W, Chen K, Gheysens O, Cao Q, Wang S X, Gambhir S S and Chen X 2006 Nano Lett. 6 669-76
37. Clements B A, Bai J, Kucharski C, Farrell L L, Lavasanifar A, Ritchie B, Ghahary A and Uludag H 2006 Biomacromolecules 7 1481-8
38. Zhang X, Xiong Z, Wu Y, Cai W and Tseng J R 2006 J. Nucl. Med. 47 113-21
39. Dubertret B, Calame M and Libchaber A J 2001 Nat. Biotechnol. 19 365-70
40. Sathe T R, Agrawal A and Nie S 2006 Anal. Chem. 78 5627-32
41. Josephson L, Kircher M F, Mahmood U, Tang Y and Weissleder R 2002 Bioconj. Chem. 13 554-60
42. Oba M, Fukushima S, Kanayama N, Aoyagi K, Nishiyama N, Koyama H and Kataoka K 2007 Bioconj. Chem. 18 1415-23
43. Zhang Y, Kohler N and Zhang M 2002 Biomaterials 23 1553-61
44. Montet X, Funovics M, Montet-Abou K, Weissleder R and Josephson L 2006 J. Med. Chem. 49 6087-93